
Non-profit drug maker will provide insulin for no more than $30 a vial
CNN
Civica Rx, a nonprofit generic drug maker backed by hospitals, insurers and philanthropies, plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval. Insulin has been a poster child for the soaring cost of prescription drugs.
Insulin, which more than 8 million Americans with diabetes depend on, has been a poster child for the soaring cost of prescription drugs.
Though insulin was discovered more than a century ago and costs little to make, the list price of the brand name products that Civica Rx is targeting is roughly $300 per vial, according to the Gary and Mary West Foundation, which co-founded Civica Rx. The cost has nearly tripled since 2010.

One year ago this week, Joe Biden was president. I was in Doha, Qatar, negotiating with Israel and Hamas to finalize a ceasefire and hostage release deal. The incoming Trump team worked closely with us, a rare display of nonpartisanship to free hostages and end a war. It feels like a decade ago. A lot can happen in a year, as 2025 has shown.












